Geroscience examines the underlying biology of aging to delay chronic diseases and extend the healthy years of human life.

FDA's elevated meeting status signals transition from biomarker data discussions to Accelerated Approval discussions OS ...

The collaboration brings together Scipher Medicine’s expertise in precision medicine and molecular patient stratification with Senelix’s therapeutic development capabilities to accelerate the ...

The metabolism–cancer axis is currently at a critical inflection point. A landmark August 2025 JAMA Oncology study reported a 17% reduction in overall ...

Many people know that finding cancer early, before it spreads, may help increase the chances of treating and surviving cancer ...

Interim observations from the Phase 2 TRAILHEAD study show continued improvement in handgrip strength, overall stability of elbow and shoulder ...

Discover why biomarkers are critical in modern drug discovery and clinical trials, enabling better target validation.

Dyne announced the results of new analyses of cardiac and pulmonary function amongst all DELIVER participants who were randomized to z-rostudirsen treatment at baseline (any dose 1) and for whom ...

Investors are scrutinizing the prospects for some drugs in the pipeline following a string of recent rejections from the U.S.

TD Cowen 46th Annual Health Care Conference March 2, 2026 10:30 AM ESTCompany ParticipantsSujal Patel - Co-Founder, ...

After teasing a new regulatory process for personalized genetic medicines at the end of last year, the FDA today unveiled draft guidance for an approval pathway that could see custom CRISPR therapies, ...

NEW YORK, NY, UNITED STATES, January 16, 2026 /EINPresswire.com/ — OS Therapies Inc. (NYSE American: OSTX) (“OS Therapies” or “the Company”), the world ...